Absci Corporation

ABSI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.65+4.10%

2026-09-18

Financials

Valuation Metrics

Absci Corporation's Market Cap is $1.66B. At end of 2025 it was $502M. Ranked #2189 of 3,121 in US market (top 70%), #864 of 1,463 on NASDAQ (top 59%), #160 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 60%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.66B	US#2,189/3,121 Sec#160/266
Revenue	$2M	US#2,872/3,121 Sec#190/266
Net Income	$-121M	US—/3,121 Sec—/266
Total Assets	$269M	US#2,940/3,121 Sec#221/266
Net Assets	$246M	US#2,608/3,121 Sec#174/266
Value
P/B	6.73x	US#2,395/3,121 Sec#163/266
P/S	591.46x	US#2,981/3,121 Sec#195/266
FCF Yield	-6.58%	US—/3,121 Sec—/266
Profitability
ROE	-49.19%	US#2,676/3,121 Sec#155/266
ROA	-45.02%	US#2,968/3,121 Sec#199/266
Op. Margin	-8411.27%	US#2,870/3,121 Sec#186/266
Revenue Growth	-62.28%	US#2,753/3,121 Sec#169/266
Financial Health
Debt Ratio	9.26%	US#99/3,121 Sec#45/266
Total Debt	$4M	US#2,933/3,121 Sec#224/266
FCF	$-109M	US#2,645/3,121 Sec#149/266
Cash	$108M	US#2,189/3,121 Sec#169/266
Current Ratio	10.63x	US#238/3,121 Sec#75/266
Performance
1Y Return	258.74%	US#36/3,121 Sec#16/266
1M Return	-3.40%	US#507/3,121 Sec#59/266
From 52W High	-19.98%	US#1,699/3,121 Sec#130/266
1Y MDD	-54.00%	US#2,598/3,121 Sec#195/266
Trading
Volume	6,367,928 shares	US#181/3,121 Sec#12/266
Trading Value	$60M	US#985/3,121 Sec#69/266
Per Share
EPS	$-0.71	US—/3,121 Sec—/266
BPS	$1.43	US#2,640/3,121 Sec#190/266